Aldurazyme
Aldurazyme ingredients
| Active ingredient | Strength |
|---|---|
| Laronidase | 2.9 mg/5mL |
What Aldurazyme is used for
The FDA lists the approved uses on the official label (below). In the EU, laronidase is approved as Aldurazyme for:
Aldurazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis I (MPS I; alpha-L-iduronidase deficiency) to treat the nonneurological manifestations of the disease.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Aldurazyme
- Generic name
- Laronidase
- Made by
- Genzyme Corporation
- Forms
- Injection, Solution, Concentrate
- Given
- Intravenous
- Drug class
- Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
- FDA approval
- Biologic licence (BLA) BLA125058
- On the US market since
- 2003
Official information
- MedlinePlus drug information (search for Laronidase)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Aldurazyme?
Aldurazyme (Laronidase) is a specialist medicine made by Genzyme Corporation, approved by the US FDA.
What are the ingredients of Aldurazyme?
Aldurazyme contains Laronidase (2.9 mg/5mL).
Is Aldurazyme approved in Europe?
The same active substance is approved in the EU as Aldurazyme.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA